Nature

Genetic Polymorphisms and Treatment Outcomes in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC) remains one of the leading causes of cancer-related mortality worldwide. Genetic polymorphisms—particularly single nucleotide polymorphisms (SNPs)—in genes that ...
ascopubs.org

Single nucleotide polymorphisms (SNPs) of hypoxia-related and DNA repair genes associated with toxicity and clinical outcome in head and neck squamous cell carcinoma patients ...

Evaluating the cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients submitted to concurrent chemoradiation. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
ascopubs.org

Association of the EGFR gene polymorphisms with clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with gefitinib

GTP as a biomarker of inosine monophosphate dehydrogenase (IMPDH) inhibition, in patients with advanced hematological malignancies treated with AVN944 in a phase I trial No significant financial ...